You have 9 free searches left this month | for more free features.

Condition

Adult Disease (3)

Advanced Solid Tumor (2)

Multiple Myeloma (2)

Cutaneous Melanoma (1)

Hematologic Diseases (1)

Melanoma (Skin) (1)

Metastatic Melanoma (1)

Refractory Multiple Myeloma (1)

Relapsed Cancer (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Anaveon AG (3)

Collaborator

Intervention

anv419 (3)

daratumumab (1)

ipilimumab (1)

lenalidomide with low-dose dexamethasone (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

anv419

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Myeloma, Relapsed Cancer, Refractory Multiple Myeloma Trial (ANV419, Lenalidomide with low-dose dexamethasone,

Not yet recruiting

Multiple Myeloma
+4 more

ANV419
+2 more

(no location specified)

Nov 29, 2022

Advanced Solid Tumor, Adult Disease, Multiple Myeloma Trial in Spain, Switzerland, United Kingdom (ANV419, CPI or

Recruiting

Advanced Solid Tumor
+2 more

ANV419

Barcelona, Spain
+4 more

Dec 19, 2022

Melanoma (Skin), Cutaneous Melanoma, Adult Disease Trial in France, Spain, United States (ANV419, Pembrolizumab, Ipilimumab)

Recruiting

Melanoma (Skin)
+4 more

ANV419
+2 more

Bloomington, Minnesota
+7 more

Jan 31, 2023